<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-91588" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>High Frequency Ventilation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Murthy</surname>
            <given-names>Pooja R.</given-names>
          </name>
          <aff>Manipal Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>AK</surname>
            <given-names>Ajith Kumar</given-names>
          </name>
          <aff>Manipal Hospitals</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pooja Murthy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ajith Kumar AK declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-91588.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>High-frequency ventilation (HFV) is a type of ventilation utilized when conventional ventilation fails. In this technique, the set respiratory rate greatly exceeds the normal breathing rate. In this rescue strategy, the tidal volume delivered is significantly less and can also be less than dead space ventilation.<xref ref-type="bibr" rid="article-91588.r1">[1]</xref>&#x000a0;This&#x000a0;topic is presented for historical purposes as it is no longer used in adults, only in neonates.</p>
        <p>A few stated advantages of this technique are:</p>
        <list list-type="bullet">
          <list-item>
            <p>It reduces the risk of volutrauma and thus helps prevent ventilator-induced lung injury (VILI).</p>
          </list-item>
          <list-item>
            <p>It also maintains constant alveolar inflation, thus preventing the inflate-deflate cycle and improving oxygenation.</p>
          </list-item>
        </list>
        <p>There are mainly&#x000a0;4 types of HFV:</p>
        <list list-type="order">
          <list-item>
            <p>High-frequency oscillatory ventilation (HFOV)</p>
          </list-item>
          <list-item>
            <p>High-frequency positive pressure ventilation (HPPV)</p>
          </list-item>
          <list-item>
            <p>High-frequency jet ventilation (HJV)</p>
          </list-item>
          <list-item>
            <p>High-frequency percussive ventilation (HFPV)<xref ref-type="bibr" rid="article-91588.r2">[2]</xref></p>
          </list-item>
        </list>
        <p>
<bold>HFOV</bold>
</p>
        <p>This is&#x000a0;1 of the most common methods of HFV. It is often used as a rescue strategy when conventional ventilation fails in severe acute respiratory distress syndrome (ARDS). In this technique, the tidal volume set is less than dead space ventilation, and respiratory rates range from 300 to 900 /minute.&#x000a0;The technique uses a reciprocating diaphragm to deliver very high respiratory rates and is connected to a standard endotracheal tube. The primary setting is mean airway pressure (MAP), as the flow oscillates around a constant MAP due to high respiratory rates (frequency). The settings involved are respiratory rate (or frequency), set directly, and MAP, often set by adjusting inspiratory flow rates and expiratory valve (positive end-expiratory&#x000a0;pressure). In some machines, the MAP is set directly. The tidal volume delivered is very low and is less than anatomical dead space. The tidal volume is also known as amplitude and is determined by various factors like the size of the endotracheal tube and the respiratory rate/ frequency set.<xref ref-type="bibr" rid="article-91588.r3">[3]</xref>&#x000a0;The mechanism of maintaining constant mean airway pressure helps in alveolar recruitment and improvement of oxygenation. The low tidal volumes prevent volutrauma and VILI.&#x000a0;It is used as&#x000a0;1 of the rescue methods in patients with severe ARDS when conventional ventilation has failed. In neonatal patients, HFOV can be used in premature lungs as the first line to prevent lung injury by conventional ventilation.&#x000a0;</p>
        <p>
<bold>HJV</bold>
</p>
        <p>This method is mainly used in neonates. This technique delivers a gas jet via a 14-16 gauge cannula inserted in the endotracheal tube. It delivers a respiratory rate of about 100 to 150 per minute. It provides very low tidal volumes of less than 1ml per kg. Exhalation is passive. It is often combined with conventional ventilation for the reinflation of the lungs. Taylor dispersion is the most common method of gas exchange in HFJV.<xref ref-type="bibr" rid="article-91588.r4">[4]</xref>&#x000a0;</p>
        <p>
<bold>HFPPV</bold>
</p>
        <p>It is delivered using a conventional ventilator where respiratory rates are set at maximum limits. This technique is obsolete and is rarely used.&#x000a0;</p>
        <p>
<bold>HFPV</bold>
</p>
        <p>This involves a combination of&#x000a0;HFV and conventional ventilation (pressure control mode). It can be described as HFOV oscillating between&#x000a0;2 different pressure levels. It is presumed to have lesser risks of barotrauma and improve oxygenation compared to conventional ventilation alone. The general requirements for sedation and paralysis are lower in this mode than in other methods of HFV. It is also more efficient in clearing secretions.<xref ref-type="bibr" rid="article-91588.r4">[4]</xref></p>
      </sec>
      <sec id="article-91588.s2" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>During conventional mechanical ventilation, gas transfer happens by bulk transport of gas molecules from large central airways to smaller peripheral airways. This requires a higher tidal volume than dead space ventilation. During HFV, this is not possible as the tidal ventilation delivered is low. One well-known mechanism for gas transfer in HFV is bulk transfer by convection, which may contribute to gas exchange in proximal airways, though it&#x000a0;plays only a minor role in peripheral gas exchange.</p>
        <p>Turbulence is another method of gas transfer, especially in larger airways. In this theory, the different velocity profiles of asymmetric particles lead to net convective transport. This mode of gas exchange is seen most often in the bifurcation of airways. Taylor dispersion and molecular diffusion are some of the most critical gas exchange mechanisms during HFOV. The other mechanisms described include pendelluft, cardiogenic mixing, and collateral ventilation.<xref ref-type="bibr" rid="article-91588.r5">[5]</xref></p>
      </sec>
      <sec id="article-91588.s3" sec-type="Indications">
        <title>Indications</title>
        <p>Indications for HFV in adults and neonates include:</p>
        <p><bold>Adults</bold>&#x000a0;<xref ref-type="bibr" rid="article-91588.r6">[6]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>It is mainly used in severe ARDS&#x000a0; to prevent VILI.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Large air leak syndromes with the inability to keep lungs open&#x000a0; like bronchopleural fistula, pneumothorax, pulmonary interstitial emphysema</p>
          </list-item>
          <list-item>
            <p>Failure of conventional mechanical ventilation&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Refractory hypoxemia&#x000a0; as a rescue therapy</p>
          </list-item>
        </list>
        <p>
<bold>Neonates</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Persistent pulmonary hypertension&#x000a0;</p>
          </list-item>
          <list-item>
            <p>ARDS</p>
          </list-item>
          <list-item>
            <p>Pulmonary interstitial emphysema&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Meconium aspiration&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pulmonary hypoplasia&#x000a0;</p>
          </list-item>
        </list>
        <p>There is no classic recommendation for HFOV in adults. It is mainly used as rescue therapy in severe ARDS. It is used as&#x000a0;1 of the methods to prevent VILI. It is also used in patients with bronchopleural fistula. It is beneficial when ventilation is difficult and lungs cannot be kept open, like pneumothorax and pulmonary interstitial emphysema. It is also used in ARDS due to inhalational injury, blunt trauma chest, and even in patients with traumatic brain injury with high intracranial pressure.<xref ref-type="bibr" rid="article-91588.r7">[7]</xref></p>
      </sec>
      <sec id="article-91588.s4" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>There are no absolute contraindications for HFOV. However, HFOV can be less effective in certain diseases with high intrathoracic pressure and increased airway resistance, like bronchial asthma. It can lead to air trapping and hyperinflation. It can also lead to complications like barotrauma and air leak syndromes like pneumothorax, pulmonary interstitial emphysema, and pneumomediastinum. It can also be avoided in patients with intracranial hemorrhage and severe sepsis with multiorgan failure.<xref ref-type="bibr" rid="article-91588.r8">[8]</xref></p>
      </sec>
      <sec id="article-91588.s5" sec-type="Equipment">
        <title>Equipment</title>
        <p>There are various brands of&#x000a0;HFV devices.<xref ref-type="bibr" rid="article-91588.r8">[8]</xref><xref ref-type="bibr" rid="article-91588.r9">[9]</xref><xref ref-type="bibr" rid="article-91588.r10">[10]</xref></p>
      </sec>
      <sec id="article-91588.s6" sec-type="Personnel">
        <title>Personnel</title>
        <p>Skilled personnel are necessary to set up the machine and troubleshoot alarms.</p>
      </sec>
      <sec id="article-91588.s7" sec-type="Preparation">
        <title>Preparation</title>
        <p>The machine must be checked for proper functioning, alarms must be set, and the patient's MAP on a conventional ventilator must be noted.</p>
      </sec>
      <sec id="article-91588.s8" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>
<bold>SETTINGS IN HFOV&#x000a0;</bold>
<xref ref-type="bibr" rid="article-91588.r6">[6]</xref>
</p>
        <p>The set variables are:</p>
        <list list-type="order">
          <list-item>
            <p>Respiratory rate/Frequency</p>
          </list-item>
          <list-item>
            <p>Amplitude/Power/Delta P&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Mean airway pressure (Paw)</p>
          </list-item>
          <list-item>
            <p>Bias flow</p>
          </list-item>
          <list-item>
            <p>Inspiratory time</p>
          </list-item>
          <list-item>
            <p>FiO<sub>2</sub></p>
          </list-item>
        </list>
        <p><bold>Frequency</bold>&#x000a0;</p>
        <p>The rate at which the machine oscillates is set by setting the frequency. A 1 Hz frequency is equal to 60 oscillations per minute. As the inspiration-to-expiration ratio is fixed, tidal volume/amplitude decreases as the frequency increases. Higher frequencies are useful to decrease barotrauma as the pressure change transmitted to alveoli is less at high frequencies. This also increases the zone of safety for ventilation and leads to homogenous aeration of alveoli. The frequency set is usually between 3 to 6 Hz on initiation; it can be as high as&#x000a0;10 to 15 Hz.</p>
        <p>
<bold>Amplitude/Delta P</bold>
</p>
        <p>This is&#x000a0;the primary determinant of tidal volume. It occurs due to the piston movement towards or away from a patient's airway. The voltage across the piston, in turn, determines this. Thus, an increase in polarity increases the amplitude and piston movement and, therefore, tidal volumes above the mean airway pressure. In HFOV, inspiration and expiration are both active processes. The amplitude settings are initiated and subsequently adjusted according to PaCO<sub>2</sub> levels.&#x000a0;</p>
        <p>
<bold>Mean Airway Pressure (Paw)</bold>
</p>
        <p>This can be adjusted directly or indirectly. Mean airway pressure is the main determinant of oxygenation, and an increase in Paw improves oxygenation. The settings are adjusted according to oxygenation requirements. Most often, the value initiated&#x000a0;is 5 cm of H<sub>2</sub>O above plateau pressure in conventional ventilation. Mean airway pressure is adjusted slowly based on saturation in increments of 2 cm H<sub>2</sub>O. However, the maximum value is 35 cm of H<sub>2</sub>O, and the usual targets are less than 30 cm of H2O.</p>
        <p>
<bold>Bias Flow</bold>
</p>
        <p>This is the gas flow rate in the ventilator and the circuit apparatus. In HFV, the bias flow is usually around 40 L/min to a maximum of 60 L/min.&#x000a0;An increase in bias flow is an indirect method of increasing MAP and oxygenation. The bias flow needed&#x000a0;is high in patients with air leak syndromes.</p>
        <p>
<bold>Inspiratory Time</bold>
</p>
        <p>The inspiratory time set is always less than 50% of the total respiratory cycle, and most often, it is set at 33%.&#x000a0;An increase in inspiratory time increases mean airway pressure and thus improves oxygenation. However, it can increase the risks of barotrauma; thus, it is mostly kept constant.</p>
        <p>
<bold>Initial Setting for HFOV&#x000a0;</bold>
<xref ref-type="bibr" rid="article-91588.r8">[8]</xref>
</p>
        <p>The initial settings are a primary guide and must be adjusted according to subsequent arterial blood gas and clinical assessment.&#x000a0;The initial parameters are usually set as below:</p>
        <list list-type="order">
          <list-item>
            <p>Bias flow is usually set from lower values, starting from 20 L/min to 35 L/min, and is adjusted subsequently as per the patient&#x02019;s needs.</p>
          </list-item>
          <list-item>
            <p>Inspiratory time is often constant and is set at 33%, giving an inspiration-to-expiration ratio of 1&#x000a0;to 2.</p>
          </list-item>
          <list-item>
            <p>Respiratory rate/frequency are the main determinants of PaCO<sub>2</sub> and are set between 3 to 15 Hz. It is most often initiated at 5 to 6 Hz, giving a respiratory&#x000a0;rate of about 300 per minute. Subsequent adjustments are made by serial ABG monitoring.</p>
          </list-item>
          <list-item>
            <p>The amplitude (&#x00394;P) is the primary determinant of tidal volume and is initiated and titrated by looking for chest wiggles/vibrations. In infants, a chest wiggle up to the umbilicus is targeted, whereas in children and adults, chest wiggles up to the pelvic region and the mid-thigh are targeted, respectively.&#x000a0;It is usually set at about 20 to 30 cm&#x000a0;H<sub>2</sub>O higher than patients' PaCO<sub>2&#x000a0;</sub>on conventional ventilation.</p>
          </list-item>
          <list-item>
            <p>FiO<sub>2</sub> and mean airway pressure settings mainly determine oxygenation. When initiating HFOV, the mPaw is set at 5 cm H2O above the mPaw seen on a conventional ventilator. FiO<sub>2</sub> is initially set at 1.0 and subsequently tapered as per the patient's oxygenation requirements, titrated to a target SpO<sub>2</sub> of 88&#x000a0;to 92%. Some patients may need a recruitment maneuver before initiating HFOV.</p>
          </list-item>
        </list>
        <p><bold>Weaning from HFOV&#x000a0;</bold><xref ref-type="bibr" rid="article-91588.r8">[8]</xref>&#x000a0;</p>
        <p>Weaning from HFOV is not based on fixed protocols, and various methods are followed. The process involves weaning to an extent where the patient can tolerate conventional ventilation.&#x000a0;The parameters that determine weaning readiness are FiO<sub>2</sub> and mean airway pressures. Once oxygenation goals are met,&#x000a0;2 steps can be followed. The first step is to wean FiO<sub>2</sub> to less than 60%, considering a saturation of more&#x000a0;than 88%, and the next step is to decrease MAP in increments of 2 cm H<sub>2</sub>O to achieve a MAP of 30 cm H<sub>2</sub>O.&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>Once the above is done, the next step is to slowly wean FiO<sub>2</sub> to 0.4 and the MAP in increments of 2 cm to reach a final goal of 20 to 25 cm H<sub>2</sub>O.</p>
          </list-item>
          <list-item>
            <p>After achieving the above, the next approach is to transition the patient to conventional lung-protective ventilation and target saturation of more than 88% with mPaw of 20 to 25 cms for the next 24 hours.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Weaning failure is considered when the patient is weaned to conventional low tidal volume ventilation and fails to maintain saturation above 88% in the initial 48 hours.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-91588.s9" sec-type="Complications">
        <title>Complications</title>
        <p>&#x000a0;HFV is not without complications. The following are the challenges faced in HFV:</p>
        <list list-type="bullet">
          <list-item>
            <p>Its efficacy is questionable in patients with high airway resistance and can lead to air trapping and barotrauma like pneumothorax, pneumomediastinum, pneumopericardium, and pulmonary interstitial emphysema.<xref ref-type="bibr" rid="article-91588.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>It can also cause harmful heart-lung interactions and lead to high intrathoracic pressures, thus causing decreased venous return and cardiac output.<xref ref-type="bibr" rid="article-91588.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>As it is an unorthodox ventilation method, it leads to decreased clearance of secretions and higher risks of secondary sepsis.<xref ref-type="bibr" rid="article-91588.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Other limitations include transport difficulties, noisy machines causing problems in clinical examinations, and delayed identification of complications.<xref ref-type="bibr" rid="article-91588.r12">[12]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-91588.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Mechanical ventilation, despite the unavoidable need, tends to cause ventilator-induced lung injury. In&#x000a0;positive pressure ventilation, the most common mechanisms that lead to lung injury are barotrauma, volutrauma, and atelectrauma (due to repeated opening and closing of alveoli). Thus, high tidal volumes and high pressures (plateau and peak air pressures) cause and aggravate ventilator-induced lung injury. The most proven preventive method is low tidal volume ventilation, as proposed by the ARDS network.<xref ref-type="bibr" rid="article-91588.r13">[13]</xref>&#x000a0;In HFV, this is avoided as the entire aeration cycle operates in the safe zone, thus preventing overdistention, which causes VILI. It also prevents derecruitment and avoids atelectrauma and barotrauma.&#x000a0;It prevents barotrauma and helps improve the ventilation-to-perfusion ratio by allowing uniform aeration of the lungs.<xref ref-type="bibr" rid="article-91588.r6">[6]</xref>&#x000a0;The tidal volume used in HFOV is less than dead space volume, preventing cyclical opening and closing of alveoli. By this, it delivers a constant MAP, thereby reducing VILI. It also helps in recruitment by using high positive end-expiratory&#x000a0;pressure.</p>
        <p>Few trials have been done to study the risks and clinical benefits of HFOV&#x000a0; in ARDS. In the OSCILLATE trial, adult patients with moderate to severe ARDS were randomized to receive conventional ventilation with ARDS&#x000a0; protocol or HFOV. This study noted significantly higher mortality in the HFOV group (41%) than in conventional ventilation (35%). The trial concluded that early institution of HFOV&#x000a0; in moderate to severe ARDS was not beneficial and could be harmful.<xref ref-type="bibr" rid="article-91588.r14">[14]</xref>&#x000a0;The OSCAR randomized control trial was a multicenter study in the UK in patients with severe ARDS. It proved that there was no difference in mortality between the study groups, and HFO may not be beneficial.<xref ref-type="bibr" rid="article-91588.r15">[15]</xref>&#x000a0;The RESTORE study done in pediatric ARDS patients found that the use of HFOV in ARDS&#x000a0; led to increased sedation requirements and length of ICU stay.<xref ref-type="bibr" rid="article-91588.r16">[16]</xref>&#x000a0;A meta-analysis published in 2017 analyzed that HFOV was not useful but could be potentially harmful when used in mild to moderate ARDS with higher PO<sub>2</sub>/FiO<sub>2</sub> ratios. However, its use as a potential modality, mainly as rescue therapy in refractory hypoxemia, is still considered beneficial. Thus, in patients with severe ARDS with refractory hypoxemia, the use of HFOV may help, especially when proning and ECMO are impossible or unavailable.<xref ref-type="bibr" rid="article-91588.r17">[17]</xref></p>
      </sec>
      <sec id="article-91588.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Successful execution of HFV highlights the role of the interprofessional team in evaluating and improving care for patients who need close coordination and cooperation between various healthcare providers &#x00026; specialty teams. HFV is currently accepted only as a rescue strategy in refractory hypoxemia, where other conventional or supportive options are impossible or unavailable. The decision to utilize HFV must be made after close interaction and coordination between the intensive care, pulmonology, and respiratory therapy teams. Biomedical or technical assistance may be required at the bedside due to a lack of experience and familiarity with this ventilatory mode among many providers. Close interaction and coordination between various healthcare professionals indisputably bring&#x000a0;out the best outcome for the patient.</p>
      </sec>
      <sec id="article-91588.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=91588&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=91588">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/91588/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=91588">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-91588.s13">
        <title>References</title>
        <ref id="article-91588.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>TE</given-names>
              </name>
            </person-group>
            <article-title>High-frequency mechanical ventilation principles and practices in the era of lung-protective ventilation strategies.</article-title>
            <source>Respir Care Clin N Am</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <page-range>247-60</page-range>
            <pub-id pub-id-type="pmid">12481818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mutz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Baum</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Benzer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Putz</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Clinical experience with several types of high frequency ventilation.</article-title>
            <source>Acta Anaesthesiol Scand Suppl</source>
            <year>1989</year>
            <volume>90</volume>
            <fpage>140</fpage>
            <page-range>140-4</page-range>
            <pub-id pub-id-type="pmid">2648733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fessler</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Derdak</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ferguson</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Hager</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Kacmarek</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Brower</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>A protocol for high-frequency oscillatory ventilation in adults: results from a roundtable discussion.</article-title>
            <source>Crit Care Med</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>35</volume>
            <issue>7</issue>
            <fpage>1649</fpage>
            <page-range>1649-54</page-range>
            <pub-id pub-id-type="pmid">17522576</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gluck</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Heard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mohr</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Calkins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Landow</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Use of ultrahigh frequency ventilation in patients with ARDS. A preliminary report.</article-title>
            <source>Chest</source>
            <year>1993</year>
            <month>May</month>
            <volume>103</volume>
            <issue>5</issue>
            <fpage>1413</fpage>
            <page-range>1413-20</page-range>
            <pub-id pub-id-type="pmid">8486020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pillow</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>High-frequency oscillatory ventilation: mechanisms of gas exchange and lung mechanics.</article-title>
            <source>Crit Care Med</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>3 Suppl</issue>
            <fpage>S135</fpage>
            <page-range>S135-41</page-range>
            <pub-id pub-id-type="pmid">15753719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stawicki</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Goyal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sarani</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>High-frequency oscillatory ventilation (HFOV) and airway pressure release ventilation (APRV): a practical guide.</article-title>
            <source>J Intensive Care Med</source>
            <year>2009</year>
            <season>Jul-Aug</season>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>215</fpage>
            <page-range>215-29</page-range>
            <pub-id pub-id-type="pmid">19617228</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>High-frequency percussive ventilation.</article-title>
            <source>Crit Care Med</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>3 Suppl</issue>
            <fpage>S241</fpage>
            <page-range>S241-5</page-range>
            <pub-id pub-id-type="pmid">15753734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyers</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ari</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>High-frequency oscillatory ventilation: A narrative review.</article-title>
            <source>Can J Respir Ther</source>
            <year>2019</year>
            <volume>55</volume>
            <fpage>40</fpage>
            <page-range>40-46</page-range>
            <pub-id pub-id-type="pmid">31297448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Custer</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaczka</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Mulreany</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Hager</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Easley</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>In vitro performance comparison of the Sensormedics 3100A and B high-frequency oscillatory ventilators.</article-title>
            <source>Pediatr Crit Care Med</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>e176</fpage>
            <page-range>e176-80</page-range>
            <pub-id pub-id-type="pmid">21037502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wheeler</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Schm&#x000f6;lzer</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Morley</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>High-frequency ventilation with the Dr&#x000e4;ger Babylog 8000plus: measuring the delivered frequency.</article-title>
            <source>Acta Paediatr</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>100</volume>
            <issue>1</issue>
            <fpage>67</fpage>
            <page-range>67-70</page-range>
            <pub-id pub-id-type="pmid">20712839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pellicano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tingay</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Mills</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Fasulakis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Morley</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Dargaville</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Comparison of four methods of lung volume recruitment during high frequency oscillatory ventilation.</article-title>
            <source>Intensive Care Med</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>35</volume>
            <issue>11</issue>
            <fpage>1990</fpage>
            <page-range>1990-8</page-range>
            <pub-id pub-id-type="pmid">19756507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eastman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Delagarza</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Olson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brakenridge</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Foteh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Friese</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>High-frequency percussive ventilation improves oxygenation in trauma patients with acute respiratory distress syndrome: a retrospective review.</article-title>
            <source>Am J Surg</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>192</volume>
            <issue>2</issue>
            <fpage>191</fpage>
            <page-range>191-5</page-range>
            <pub-id pub-id-type="pmid">16860628</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Acute Respiratory Distress Syndrome Network</collab>
              <name>
                <surname>Brower</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Matthay</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schoenfeld</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Wheeler</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>2000</year>
            <month>May</month>
            <day>04</day>
            <volume>342</volume>
            <issue>18</issue>
            <fpage>1301</fpage>
            <page-range>1301-8</page-range>
            <pub-id pub-id-type="pmid">10793162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferguson</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Guyatt</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hand</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Austin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Matte</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Walter</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Lamontagne</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Granton</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Arabi</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Arroliga</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Slutsky</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Meade</surname>
                <given-names>MO</given-names>
              </name>
              <collab>OSCILLATE Trial Investigators</collab>
              <collab>Canadian Critical Care Trials Group</collab>
            </person-group>
            <article-title>High-frequency oscillation in early acute respiratory distress syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>2013</year>
            <month>Feb</month>
            <day>28</day>
            <volume>368</volume>
            <issue>9</issue>
            <fpage>795</fpage>
            <page-range>795-805</page-range>
            <pub-id pub-id-type="pmid">23339639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lall</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hulme</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>MacKenzie</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tunnicliffe</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Rowan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cuthbertson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>McCabe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lamb</surname>
                <given-names>S</given-names>
              </name>
              <collab>OSCAR collaborators</collab>
            </person-group>
            <article-title>A randomised controlled trial and cost-effectiveness analysis of high-frequency oscillatory ventilation against conventional artificial ventilation for adults with acute respiratory distress syndrome. The OSCAR (OSCillation in ARDS) study.</article-title>
            <source>Health Technol Assess</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>23</issue>
            <fpage>1</fpage>
            <page-range>1-177, vii</page-range>
            <pub-id pub-id-type="pmid">25800686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bateman</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Borasino</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Asaro</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Cheifetz</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Diane</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wypij</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Curley</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Reply: It Is Too Early to Say No Place for High-Frequency Oscillatory Ventilation in Children with Respiratory Failure.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2016</year>
            <month>Aug</month>
            <day>15</day>
            <volume>194</volume>
            <issue>4</issue>
            <fpage>522</fpage>
            <pub-id pub-id-type="pmid">27525465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91588.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meade</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hanna</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Bachman</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Bollen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Slutsky</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Lamb</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Adhikari</surname>
                <given-names>NKJ</given-names>
              </name>
              <name>
                <surname>Mentzelopoulos</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Sud</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brower</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stenzler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guyatt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ferguson</surname>
                <given-names>ND</given-names>
              </name>
            </person-group>
            <article-title>Severity of Hypoxemia and Effect of High-Frequency Oscillatory Ventilation in Acute Respiratory Distress Syndrome.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2017</year>
            <month>Sep</month>
            <day>15</day>
            <volume>196</volume>
            <issue>6</issue>
            <fpage>727</fpage>
            <page-range>727-733</page-range>
            <pub-id pub-id-type="pmid">28245137</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
